News

The University of Oxford said that it had paused a small UK trial testing the COVID-19 vaccine it developed with AstraZeneca Plc in children and teenagers, as it waits for more data on rare blood clotting issues in adults...

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced the acquisition of ADC Biotechnology, a UK based bioconjugation development services business specialising in antibody drug conjugates (ADCs). This follows an announcement by Sterling in December of a...

Avantor Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, was named Best Bioprocessing Supplier in Single-Use Manufacturing at the Asia-Pacific Bioprocessing Excellence Awards 2021 held...

Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced it has acquired Critical Transport Solutions Australia Pty Ltd , a market leader in providing premium healthcare logistics management services, specializing in time-...

Sanofi announced an investment of more than €600 million in a new vaccine manufacturing facility at its existing site in Toronto, Canada. The investment in a new facility will provide additional antigen and filling capacity for Sanofi’s Fluzone® High-Dose...

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the initiation of crossover arms in two ongoing clinical trials of NVX-CoV2373, the company's COVID-19 vaccine candidate. Crossover ensures the administration of active vaccine to all...

SIRO Clinpharm, a Clinical Research Organisation in India announced that they have become a partner of ACROSS Global Alliance (ACROSS) and will help represent India in working towards the common goals and objectives of ACROSS in bridging a gap...